Latest Health News

Murray Cod Australia Limited reports a profitable FY25 with a significant biomass increase and completes a $17 million capital raise to fund infrastructure and market expansion ahead of a commercial inflection in FY26.

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.

AssetOwl Limited has had over $700,000 of debt forgiven by two lenders, significantly reducing its borrowings and strengthening its financial position.

Range International has completed the first tranche of a capital raise, securing A$1.58 million to support growth in Indonesia and the Philippines while reducing debt.

Recce Pharmaceuticals has initiated patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, targeting a significant market with high diabetes prevalence. Interim results expected in early 2026 could accelerate regulatory approval and commercial launch.

TasFoods has agreed to sell its Pyengana Dairy business for $2 million, aiming to reduce debt and refocus on its poultry supply chain. The sale awaits shareholder approval with settlement expected by early November.

Environmental Clean Technologies Limited (ECT) is set to acquire exclusive rights to Rice University’s innovative Flash Joule Heating technology, promising a breakthrough in PFAS soil remediation. The company also announces a $3 million capital raise to accelerate development and commercialisation.

Cann Group Limited has reported its first-ever EBITDA-positive month in August 2025, driven by strong B2B flower sales and disciplined cost management. The company is advancing export negotiations in Europe and preparing to launch a new Botanitech product range.

Vitura Health Limited has updated its dividend distribution details, confirming a fully franked ordinary dividend and issuing nearly 487,000 new shares under its Dividend Reinvestment Plan.

Computershare Limited has agreed to sell its UK Mortgage Services business to Pepper Advantage, marking a strategic step to streamline operations and enhance earnings quality without altering FY26 profit forecasts.

New Zealand King Salmon reported a $20.8 million net loss for the half year ending July 2025, driven by biological setbacks and reduced harvests. Despite this, the company maintains a strong balance sheet and is advancing its Blue Endeavour pilot farm and growth initiatives.

New Zealand King Salmon reports a $20.8 million net loss for the half-year ending July 2025, driven by biological asset write-downs, while maintaining EBITDA guidance and advancing key growth initiatives.